Cure8 research brief
The study suggests dietary tryptophan might reduce bacterial-induced acute lung injury in the context of colitis by altering gut–lung immune signaling, which could be relevant to IBD patients who are at risk for respiratory complications.
Researchers studying gut–lung interactions, clinicians interested in extraintestinal IBD complications, and patients curious about microbiome-related diet research (note: animal data only).
This is an animal (murine) experiment, not a human trial. Researchers induced colitis with DSS, then gave mice dietary tryptophan before exposing them to intratracheal LPS to model acute lung injury.
The authors report lower circulating LPS, reduced neutrophil and inflammatory cytokine responses in the lung, decreased TLR4/NF-κB signaling, increased AhR/IL-22 expression, reduced oxidative stress, and improved barrier proteins in tryptophan-fed mice.
The findings point to mechanisms (microbiota-derived tryptophan metabolites activating AhR) rather than clinical recommendations. Dietary tryptophan showed protective effects in this controlled laboratory setting, but safety, dosing, and effectiveness in people with IBD were not studied here.
This is a preclinical murine study (DSS colitis + LPS lung injury) reported in Nutrients; results highlight mechanisms (AhR activation, TLR4/NF-κB modulation) but do not provide evidence for clinical use of tryptophan supplements in people with IBD.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Fibrosis and stricturing are key problems in Crohn’s disease with limited therapies; this study identifies a microbiota–bile acid–GPBAR1 pathway by which a specific probiotic mix reduced inflammation and fibrosis in...
The article connects psoriasis and Crohn's disease through shared immune pathways and the gut-skin axis, which may matter because people with one condition could have signs or risks related to the other. It emphasizes...
Intestinal fibrosis and strictures remain a major cause of surgery and obstruction in Crohn’s disease, and current anti-inflammatory drugs don’t reliably prevent fibrosis. If microbial choline degradation promotes...
